Depression Is Notoriously Difficult to Treat. Can Psychedelic Therapies Help?
A highly heterogeneous disease, depression has long challenged drug developers. While effective treatments exist for some patients, many are still left behind by current regimens. Now, with the global depression treatment market projected to top $16 billion by 2027, psychedelic drug developers have their sights set on the space, with six programs currently in clinical development, according to Psychedelic Alpha.
Navigating the Neurotechnology Insurance Reimbursement Maze: Challenges and Solutions in the United States
The field of neurotechnology stands at the cusp of a revolutionary era, with promising new therapeutics and other ways of improving quality of life. From neuromodulation to brain-computer interfaces, these innovations offer hope for restored functionality, improved mental health, cognitive enhancement, and more. Despite this immense potential and excitement, there lies a formidable barrier: the complex landscape of insurance reimbursement.
Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research
SAN FRANCISCO--(BUSINESS WIRE)--Today, Osmind, the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry.
Breakthrough Mental Health Treatments with Carlene MacMillan
Our guest for this episode is Dr. Carlene MacMillan, an expert in mental health and VP of Clinical Innovation at Osmind. Carlene’s area of focus is exploring innovative mental health treatments for anxiety and depression, among other conditions.
Are Therapists Crazier than Their Patients? | Dr. Carlene MacMillan
Joe and psychiatrist Dr. Carlene MacMillan (@carlenemacmillanmd) talk about their own struggles with mental health and the stigma around personality disorders. Joe learns that narcissism might even have a cure!
‘The worst it’s ever been’: mysterious US Adderall shortage puts ADHD patients at risk
When the last tablet of Ritalin rattled softly in the plastic vial, Faati knew that sound meant trouble. The last time, they had run out of ADHD meds for three months and struggled to remember tasks or even tell time at the Washington state cafeteria where they worked. On the day they finally got a refill, they were fired for “performance reasons”.
MDMA: What Went Wrong Part 1
Welcome to the Carlat Psychiatry Podcast, keeping psychiatry honest since 2003. I’m Chris Aiken, the editor in chief of the Carlat Report. And our co-host Kellie Newsome is on vacation today.
MDMA: What Went Wrong Part 2
This month, an FDA panel voted to reject MDMA assisted psychotherapy for PTSD. That doesn’t mean the case is closed. The panel is an independent group of 11 scientists, clinicians, and patient advocates who advise the FDA. The FDA will make their final decision in August, and while there’s still a chance for approval we are not optimistic. 90% of the panel members voted against it, and the agency usually follows their advice.
Smith County Health Alert: Psychiatrist Provides Tips to be More Productive. Doctor Explains
In this column, Owen T. Muir, MD--a specialist in child and adult psychiatry--shares a strategy to help people with ADHD improve their productivity.The Big Picture: Dr. Owen Muir, Child and Adult Psychiatry, "Here's a quick and easy approach to be more productive if you have ADHD by using the Cube Timer Hack!"A Doctor's Expert Insights to Super-Charging Your ADHD in Strafford County, New HampshireFor many people with ADHD, distraction and attention, can be a daily battle.
Can Mental Disorders Be Transmitted Among Teen Peer Networks?
Carlene MacMillan, MD, a child and adolescent psychiatrist in Brooklyn, New York, and a member of the American Academy of Child and Adolescent Psychiatry, told MedPage Today that one strength of the research is that it pulled data from schools rather than from "other types of social groupings" that could have been chosen by the kids themselves.
Press Coverage
Newsletter
Sign Up for the Fermata Mailing List!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
